TRIP13 and adrenal cortex carcinoma: To examine the association between TRIP13 expression and PFI (Fig. 2C), we explored the potential negative impact of elevated TRIP13 expression on the PFI of patients with ACC, KIRC, KIRP, LIHC, MESO, LUAD, LGG, and SKCM.